Single dose and 14-day once or twice-daily pharmacokinetic study of the vaginal microbicide agent 1% tenofovir gel
Phase of Trial: Phase I
Latest Information Update: 27 May 2008
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors CONRAD
- 27 May 2008 The actual completion date has been identified as April 08 as reported by ClinicalTrials.gov.
- 27 May 2008 Status changed from recruiting to completed.
- 30 Nov 2007 New trial record.